PeptideDB

DBCO-amine 1255942-06-3

DBCO-amine 1255942-06-3

CAS No.: 1255942-06-3

DBCO-amine is a cleavable (degradable) ADC (Antibody-drug conjugate) linker used for the synthesis of antibody-conjugate
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

DBCO-amine is a cleavable (degradable) ADC (Antibody-drug conjugate) linker used for the synthesis of antibody-conjugated active molecules (ADCs).

Physicochemical Properties


Molecular Formula C18H16N2O
Molecular Weight 276.332444190979
Exact Mass 276.126
CAS # 1255942-06-3
Related CAS # DBCO-amine;1255942-06-3
PubChem CID 77078258
Appearance Off-white to yellow solid powder
LogP 3.047
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 2
Heavy Atom Count 21
Complexity 447
Defined Atom Stereocenter Count 0
InChi Key OCCYFTDHSHTFER-UHFFFAOYSA-N
InChi Code

InChI=1S/C18H16N2O/c19-12-11-18(21)20-13-16-7-2-1-5-14(16)9-10-15-6-3-4-8-17(15)20/h1-8H,11-13,19H2
Chemical Name

3-amino-1-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)propan-1-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro ADCs are made up of an antibody and an ADC cytotoxin that are joined together by an ADC linker.
References

[1]. Splicing modulator antibody-drug conjugates and methods of use. WO2019232449A1.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~361.89 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.6189 mL 18.0943 mL 36.1886 mL
5 mM 0.7238 mL 3.6189 mL 7.2377 mL
10 mM 0.3619 mL 1.8094 mL 3.6189 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.